Abstract |
Food allergies affect approximately 5% of the U.S. population and have increased in the last decade. In recent years, oral immunotherapy (OIT) has been tested in clinical trials for peanut, milk, and egg allergies in young children. OIT appears to be fairly well tolerated by most subjects and leads to desensitization with a greatly increased threshold of allergen required to induce reactions. Further approaches being investigated in preclinical studies in mouse models indicate the potential for using adjuvants, such as TLR9 agonists in combination with OIT; peptide OIT; and non- allergen specific applications such as herbal formulations. Further questions about OIT remain, including the optimal dosing and length of treatment; whether tolerance can be developed; and the exact cellular mechanisms resulting in protection following OIT. With many clinical trials underway across the United States and other countries, and a growing pipeline of preclinical research with translational potential, there is great hope for a widely applicable food allergy treatment.
|
Authors | Mike Kulis, A Wesley Burks |
Journal | Advanced drug delivery reviews
(Adv Drug Deliv Rev)
Vol. 65
Issue 6
Pg. 774-81
(Jun 15 2013)
ISSN: 1872-8294 [Electronic] Netherlands |
PMID | 23099276
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2012 Elsevier B.V. All rights reserved. |
Chemical References |
- Adjuvants, Pharmaceutic
- Drug Carriers
- Immunoglobulins
- Toll-Like Receptor 9
|
Topics |
- Adjuvants, Pharmaceutic
- Administration, Oral
- Clinical Trials as Topic
- Desensitization, Immunologic
(methods)
- Dose-Response Relationship, Drug
- Drug Carriers
(administration & dosage, pharmacokinetics)
- Drug Evaluation, Preclinical
- Egg Hypersensitivity
(immunology, therapy)
- Food Hypersensitivity
(immunology, therapy)
- Humans
- Immune Tolerance
(immunology)
- Immunoglobulins
(biosynthesis)
- Immunotherapy
(methods)
- Milk Hypersensitivity
(immunology, therapy)
- Peanut Hypersensitivity
(immunology, therapy)
- Pediatrics
- T-Lymphocytes
(immunology)
- Toll-Like Receptor 9
(agonists)
|